ArticleEndocrine journal2025
The influence of hypertensive disorders of pregnancy on the development of long-term postpartum type 2 diabetes mellitus.
Article in Endocrine journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The association between hypertensive disorders of pregnancy (HDP) and the subsequent development of type 2 diabetes (T2D) in Japanese general population remains unclear. To investigate the influence of HDP on long-term postpartum development of metabolic disorders and T2D, we conducted a population-based cross-sectional study using the 75 g oral glucose tolerance test (75g-OGTT) in 978 parous Japanese women (median age: 66 years). We further evaluated the combined effect of HDP and T2D susceptibility genes on developing T2D. HDP history was identified in 101 participants (10.3%) and associated with high blood pressure, hypertriglyceridemia, increased homeostasis model assessment 2 for insulin resistance, decreased Matsuda index and insulin secretion-sensitivity index-2, increased postprandial glucose levels during the 75g-OGTT, and increased prevalence of hypertension, metabolic syndrome and T2D. The age and BMI adjusted odds ratio (OR) for T2D was 1.74 (95%CI: 1.04-2.93) in individuals with HDP as compared to those without HDP. Stratified analyses demonstrated an increased OR of T2D prevalence for individuals with HDP history harboring the cyclin-dependent kinase 5 regulatory subunit associated protein 1-like 1 (CDKAL1) C/C genotype compared with that of the reference group after adjusting for age and current BMI (OR = 5.18 vs. reference group; 95% CI: 1.99-13.50). Further, validation analyses using bootstrap method showed high reproducibility. HDP history was associated with postpartum prevalence of hypertension, insulin resistance and T2D later in life in Japanese general population. Further, the simultaneous assessment of an HDP history and CDKAL1 genotype is valuable to predict the future T2D development (UMIN000036074).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.